Gökhan S. Hotamisligil
American geneticist / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Gökhan S. Hotamisligil?
Summarize this article for a 10 year old
Gökhan S. Hotamisligil (Turkish: Gökhan Sıddık Hotamışlıgil;[1] born June 24, 1962) is a Turkish-American physician scientist; James Stevens Simmons Chair of Genetics and Metabolism at Harvard T.H. Chan School of Public Health (HSPH); Director of the Sabri Ülker Center for Metabolic Research[2] and associate member of Harvard-MIT Broad Institute, Harvard Stem Cell Institute and the Joslin Diabetes Center.[3]
Gökhan S. Hotamisligil | |
---|---|
Born | (1962-06-24) June 24, 1962 (age 61) Rize, Turkey |
Citizenship | Turkey and US |
Alma mater | Ankara University (MD, 1986) Harvard University (PhD, 1994) |
Spouse | Selen Ciliv Hotamisligil |
Children | 2 |
Scientific career | |
Fields | Metabolism, obesity, diabetes, atherosclerosis |
Institutions | Harvard T.H. Chan School of Public Health |
Hotamisligil has been a pioneer in research efforts to explain the mechanistic basis of common chronic metabolic diseases; particularly obesity, diabetes, fatty liver disease, and atherosclerosis. His work has led to the emergence of novel concepts that have altered the understanding of metabolic disease pathogenesis.[4]